Drug conjugate comprising anti-CDH3 (P-cadherin) antibody
US9764041B2 · kind B2 · utility
0Cited by
4References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 2012 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | Apr 4, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
It is an object of the present invention to provide a drug conjugate comprising an anti-CDH3 antibody that efficiently kills cancer cells expressing CDH3. According to the present invention, there is provided an immune complex formed by binding an antibody against CDH3 or a fragment thereof having CDH3 binding ability to a chemotherapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.